FDA issued an Early Alert for Abiomed's Automated Impella Controllers due to potential safety concerns following reports of 3 deaths.

“I’m still in shock.” Also on Sunday, volunteers had begun bringing water, food, clothing and other needed goods to people cleaning up their devastated properties.

Data from multiple Phase 2 studies in patients with early cardiogenic shock or acute decompensated heart failure demonstrate that istaroxime infused intravenously can significantly improve cardiac ...

Windtree Therapeutics announces a U.S. patent for istaroxime, a potential treatment for acute heart failure, effective until 2039.